A reported exit before the first anniversary
Coefficient Bio illustrates the short-company-lifetime story. The payout remains a different question.
~$400Mreported stock-deal value for the company
What they did
The team built AI tools for biological research. TechCrunch described an eight-month-old startup; other reporting gives only a 2025 formation year. The acquisition was reported in April 2026, making the short lifetime a reported detail rather than an independently established exact interval.
What they did not choose
An AI lab was expanding into life sciences and valued an already assembled specialist team. The market for that expertise changed the opportunities available to a small company. It does not make the underlying research or team history only months old.
Figures
- Approximately $400 million in stock, reported in April 2026; the amount was not presented as a company-confirmed cash payment (Fierce Biotech, citing The Information and Eric Newcomer).
- Founded in 2025 according to the company database cited by Fierce Biotech; no exact founding date is established here.
- Sources disagree on the founding roster: Fierce Biotech names Aris Theologis, Nathan Frey and Joyce Hong; TechCrunch names Samuel Stanton and Nathan C. Frey. The conflict is unresolved.